未登录.png)
分享.png)
收藏分享 收藏 Genomic characterization reveals distinct mutational landscape of acral melanoma in East Asian基因组特征分析揭示了东亚肢端黑色素瘤独特的突变景观。
Zhang, Fenghao; Wu, Xiaowen; Jiao, Tao; Du, Haizhen; Guo, Qian; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Jiang, Dezhi; Zhang, Yuhong; Wu, Jiayan; Kong, Yan; Si, Lu 分享 收藏 Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trialToripalimab与HBM4003 (一种anti-CTLA-4的仅重链抗体) 联合治疗晚期黑色素瘤和其他实体瘤: 一项开放标签I期试验Tang, Bixia; Chen, Yu; Jiang, Yu; Fang, Meiyu; Gao, Quanli; Ren, Xiubao; Yao, Li; Huang, Gang; Chen, Jing; Zhang, Xiaoshi; Li, Rongqing; Zhao, Shuai; Gao, Meijuan; Luo, Ruixuan; Qi, Meng; Li, Feng; Zheng, Fei; Lee, Michael; Tao, Xiaolu; Duan, Rong; Guo, Jun; Chi, Zhihong; Cui, Chuanliang 分享 收藏 IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinomaCui, Chuanliang; Li, Juan; Yang, Yue; Si, Lu; Chi, Zhihong; Mao, Lili; Wang, Xuan; Tang, Bixia; Yan, Xieqiao; Li, Siming; Zhou, Li; Wei, Xiaoting; Shen, Yuping; Guo, Qun; Zheng, Shirui; Guo, Jun; Lian, Bin 分享 收藏 Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanomaDu, Yu; Dai, Jie; Mao, Lili; Wei, Xiaoting; Bai, Xue; Chen, Ling; Lin, Jing; Chi, Zhihong; Cui, Chuanliang; Sheng, Xinan; Lian, Bin; Tang, Bixia; Wang, Xuan; Yan, Xieqiao; Li, Siming; Zhou, Li; Guo, Jun; Chen, Yu; Si, Lu 分享 收藏 Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancerLei, Huizi; Ling, Yun; Yuan, Pei; Yan, Xieqiao; Wang, Lin; Shi, Yanxia; Yao, Xin; Luo, Hong; Shi, Benkang; Liu, Jiyan; He, Zhisong; Yu, Guohua; Han, Weiqing; Hu, Changlu; Chi, Zhihong; Cui, Chuanliang; Si, Lu; Fang, Jianmin; Guo, Jun; Sheng, Xinan; Zhou, Aiping; Ying, Jianming 分享 收藏 Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trialWang, Xuan; Wu, Xiaowen; Yang, Yue; Xu, Weiran; Tian, Hui; Lian, Bin; Chi, Zhihong; Si, Lu; Sheng, Xinan; Kong, Yan; Zhou, Li; Mao, Lili; Li, Siming; Tang, Bixia; Yan, Xieqiao; Bai, Xue; Guo, Jun; Cui, ChuanLiang 分享 收藏 Safety and efficacy of Pucotenlimab (HX008)-a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II studyCui, Chuanliang; Chen, Yu; Luo, Zhiguo; Zou, Zhengyun; Jiang, Yu; Pan, Hongming; Fan, Qingxia; Zhao, Jianfu; Xu, Qing; Jiang, Renbing; Wang, Xuan; Ma, Taiyang; Guo, Zhen; Si, Lu; Chi, Zhihong; Sheng, Xinan; Dou, Yiwei; Tan, Qian; Wu, Di; Guo, Jun 分享 收藏 Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysisWei, Xiaoting; Chen, Yu; Yao, Hong; Wu, Di; Li, Hang; Zhang, Rui; Chi, Zhihong; Cui, Chuanliang; Bai, Xue; Mao, Lili; Qi, Zhonghui; Li, Ke; Lan, Shijie; Chen, Lizhu; Guo, Rui; Yao, Xinyu; Lian, Bin; Kong, Yan; Dai, Jie; Tang, Bixia; Wang, Xuan; Gershenwald, Jeffrey E.; Balch, Charles M.; Guo, Jun; Si, Lu 分享 收藏 Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapyZhou, Li; Shao, Lizhi; Gao, Shunyu; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Tang, Bixia; Mao, Lili; Lian, Bin; Yan, Xieqiao; Wang, Xuan; Bai, Xue; Li, Siming; Guo, Jun; Si, Lu 分享 收藏 分享 收藏 Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I studyZhou, Li; Wu, Xiaowen; Chi, Zhihong; Si, Lu; Sheng, Xinan; Kong, Yan; Mao, Lili; Lian, Bin; Tang, Bixia; Yan, Xieqiao; Wang, Xuan; Bai, Xue; Li, Siming; Wei, Xiaoting; Li, Juan; Yang, Qing; Guo, Jun; Cui, Chuanliang 分享 收藏 An Evidence-Based Staging System for Mucosal Melanoma: A ProposalCui, ChuanLiang; Lian, Bin; Zhang, XiaoShi; Wu, Di; Li, Ke; Si, Lu; Yang, Yue; Tian, Hui; Zhou, Li; Chi, ZhiHong; Sheng, XiNan; Kong, Yan; Mao, LiLi; Wang, Xuan; Bai, Xue; Yan, XieQiao; Li, SiMing; Dai, Jie; Tang, BiXia; Wei, Xiaoting; Gershenwald, Jeffrey E.; Balch, Charles M.; Guo, Jun 分享 收藏 EZH2 Inhibitor Enhances the STING Agonist.Induced Antitumor Immunity in MelanomaXu, Tianxiao; Dai, Jie; Tang, Lirui; Yang, Lu; Si, Lu; Sheng, Xinan; Cui, Chuanliang; Chi, Zhihong; Kong, Yan; Guo, Jun 分享 收藏 Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective studyWei, Xiaoting; Wu, Di; Chen, Yu; Li, Hang; Zhang, Rui; Yao, Hong; Chi, Zhihong; Cui, Chuanliang; Bai, Xue; Mao, Lili; Qi, Zhonghui; Li, Ke; Lan, Shijie; Chen, Lizhu; Guo, Rui; Yao, Xinyu; Lian, Bin; Kong, Yan; Dai, Jie; Tang, Bixia; Wang, Xuan; Guo, Jun; Si, Lu 分享 收藏 Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanomaTang, Bixia; Mo, Jiazhi; Yan, Xieqiao; Duan, Rong; Chi, Zhihong; Cui, Chuanliang; Si, Lu; Kong, Yan; Mao, Lili; Li, Siming; Zhou, Li; Lian, Bin; Wang, Xuan; Bai, Xue; Xu, Huayan; Li, Caili; Dai, Jie; Guo, Jun; Sheng, Xinan 分享 收藏 Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa Trial达拉非尼联合曲美替尼治疗不可切除或转移性BRAF V600-Mutant肢端/皮肤黑色素瘤患者的总生存期: 一项多中心、单臂IIa期试验的长期随访Mao, Lili; Ding, Ya; Bai, Xue; Sheng, Xinan; Dai, Jie; Chi, Zhihong; Cui, Chuanliang; Kong, Yan; Fan, Yun; Xu, Yanjun; Wang, Xuan; Tang, Bixia; Lian, Bin; Yan, Xieqiao; Li, Siming; Zhou, Li; Wei, Xiaoting; Li, Caili; Guo, Jun; Zhang, Xiaoshi; Si, Lu 分享 收藏 Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical TrialsZhou, Li; Wang, Xuan; Chi, Zhihong; Sheng, Xinan; Kong, Yan; Mao, Lili; Lian, Bin; Tang, Bixia; Yan, Xieqiao; Bai, Xue; Li, Siming; Guo, Jun; Cui, Chuanliang; Si, Lu 分享 收藏 Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy-Ad hoc Analyses of Pooled Data From Two Clinical TrialsBai, Xue; Dai, Jie; Li, Caili; Cui, Chuanliang; Mao, Lili; Wei, Xiaoting; Sheng, Xinan; Chi, Zhihong; Yan, Xieqiao; Tang, Bixia; Lian, Bin; Wang, Xuan; Zhou, Li; Li, Siming; Kong, Yan; Qi, Zhonghui; Xu, Huayan; Duan, Rong; Guo, Jun; Si, Lu 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
